| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CCA.2011.07.027 |
| P8608 | Fatcat ID | release_la6i7f7i6rhmzkzmdvnsm7cdbe |
| P698 | PubMed publication ID | 21839068 |
| P50 | author | Francesca Salvianti | Q43212789 |
| Mario Pazzagli | Q54181523 | ||
| P2093 | author name string | Vincenzo De Giorgi | |
| Daniela Massi | |||
| Claudio Orlando | |||
| Pamela Pinzani | |||
| Sara Zaccara | |||
| P433 | issue | 23-24 | |
| P304 | page(s) | 2141-2145 | |
| P577 | publication date | 2011-08-03 | |
| P1433 | published in | Clinica Chimica Acta | Q5133740 |
| P1476 | title | Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations | |
| P478 | volume | 412 |
| Q47206216 | Cell-free DNA as a biomarker in stroke: Current status, problems and perspectives |
| Q26750899 | Cell-free circulating tumor DNA in cancer |
| Q34354622 | Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer |
| Q37014663 | Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology |
| Q31075758 | Circulating tumor cells in melanoma patients |
| Q89692421 | Comparison of paired cerebrospinal fluid and serum cell-free mitochondrial and nuclear DNA with copy number and fragment length |
| Q40784335 | Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma. |
| Q37306747 | Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer. |
| Q37411349 | Development and Evaluation of a Duplex Real-Time PCR Assay With a Novel Internal Standard for Precise Quantification of Plasma DNA. |
| Q38152782 | Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients. |
| Q34322575 | Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer. |
| Q40091164 | Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma |
| Q41181289 | Integrity and Quantity of Total Cell-Free DNA in the Diagnosis of Thyroid Cancer: Correlation with Cytological Classification |
| Q38700529 | Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients |
| Q34499759 | Multiparametric analysis of cell-free DNA in melanoma patients |
| Q46790693 | Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer |
| Q46462794 | Pleural fluid DNA integrity index as a diagnostic marker of malignant pleural effusion |
| Q34421199 | Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas |
| Q36219131 | Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA. |
| Q38050990 | Protein and non-protein biomarkers in melanoma: a critical update |
| Q26861681 | Recent advances in clinical applications of circulating cell-free DNA integrity |
| Q38591963 | Role of Circulating Cell-Free DNA in Cancers |
| Q37015727 | The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis |
| Q92378915 | Tumour biomarkers-Tracing the molecular function and clinical implication |
| Q64102202 | Utility of cfDNA Fragmentation Patterns in Designing the Liquid Biopsy Profiling Panels to Improve Their Sensitivity |
Search more.